The research team at Universite Laval is addressing a wide range of global health and wellbeing challenges, from chronic diseases to mental health conditions.
Their internationally-recognised work spans a vast range of health fields, including cardiology, oncology, respiratory health, infectious diseases, mental health, and public health.
The university's recent associate membership in Horizon Europe enhances its capacity for innovation.
A customized collection of grant news from foundations and the federal government from around the Web.
Nonprofit impact investing firm, Acumen, has invested $1.2 million to KZ Noir, a Rwanda-based coffee processing company owned by Kaizen Venture Partners. The investment will equip KZ Noir the funds for working capital, debt refinancing, and capacity expansion.